Is Bristol Myers Squibb Stock Undervalued At $50?
13/11 04:34
Bristol Myers Squibb (NYSE: BMY) reported its Q3 results last month, with revenues meeting and earnings beating the street estimates, and we believe that BMY stock is undervalued, as discussed below. The company reported revenue of $11.0 billion and adjusted earnings of $2.0...